Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Bavarian Nordic
company
About
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention.
- 251 - 500
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- €50M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1994
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€50M
Bavarian Nordic has raised a total of
€50M
in funding over 2 rounds. Their latest funding was raised on
May 12, 2015 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2015 | Post-IPO Debt | €50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Bavarian Nordic is funded by 1 investors.
European Investment Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
European Investment Bank
|
— | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
